Article
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer.
Breast cancer research and treatment - 1 Nov 2007
Jansson Agneta, Carlsson Jonas, Olsson Anette, Storm Petter, Margolin Sara, Gunnarsson Cecilia, Stenmark-Askmalm Marie, Lindblom Annika, Persson Bengt, Stål Olle
Abstract excerpt
In situ synthesis of oestrogens is of great importance in the development and progression of breast cancer. 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 catalyses oxidation from oestradiol to oestrone, and thereby protects the breast epithelial cells from oestradiol. Low expression of 17HSD type 2 has been associated with decreased survival in breast cancer, but no studies have investigated the mechanism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
